Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources

Sharareh Monemi,Erhan Berber,Khaled Sarsour,Jianmei Wang,Kathy Lampl,Kamal N. Bharucha,Attila Pethoe-Schramm

Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources

2016

Sharareh Monemi
Erhan Berber
Khaled Sarsour
Jianmei Wang
Kathy Lampl
Kamal N. Bharucha
Attila Pethoe-Schramm

Introduction The aim of this study was to use multiple data sources to update information on gastrointestinal perforations (GIPs) during tocilizumab (TCZ) treatment in patients with rheumatoid arthritis (RA).

Keywords:

Clinical trial
Tocilizumab
Gastrointestinal perforation
Rheumatoid arthritis
Physical therapy
Medicine
real world data
in patient
Internal medicine
Orthopedic surgery
Surgery
Rheumatology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations